Ring finger protein 39 pseudogene (RNF39 pseudogene)

Ring finger protein 39 pseudogene (RNF39 pseudogene, ENSG00000259963) is a human pseudogene located in the genome, showing high sequence similarity to the functional RNF39 gene, which encodes a RING finger domain-containing protein[1][5]. Unlike protein-coding genes, pseudogenes like ENSG00000259963 do not produce functional proteins due to loss-of-function mutations such as premature stop codons or frameshifts, though they may sometimes be transcribed[6]. Pseudogenes typically arise through duplication or retrotransposition events and may retain some regulatory roles at the RNA level, but they are not generally considered therapeutic targets or functionally relevant for traditional drug development[4][6]. No drugs, mechanisms of action, disease associations, or biomarker utilities are established for this pseudogene. Its primary biological relevance, if any, might relate to potential regulation of gene expression through RNA-mediated mechanisms, as has been hypothesized for some pseudogenes, but there is no direct evidence for this for ENSG00000259963[2][4]. Reasoning: - ENSG00000259963 is a clearly annotated pseudogene, not an active gene or therapeutic target[1][5][6]. - It is not listed as a receptor, enzyme, transporter, or protein-coding gene, nor implicated in disease, drug interactions, or clinical biomarker programs. - No standard abbreviation except the systematic gene pseudonym or locus ID (AC007012.1) and "RNF39 pseudogene." - Pseudogene does not fit into categories used for biologically active molecule classification and is not a valid "target" for therapy or pharmacology. - Therefore, is_incorrect is "true": this is not a classical druggable or disease-relevant target.

Other names

AC007012.1